CM101

• Description :

  CM101 is an anti-pathoangiogenic polysaccharide that can be derived from group B streptococcus. CM101 can inhibit inflammatory angiogenesis and accelerate wound healing in mouse models as well as minimizing scarring after spinal cord injury. CM101 also causes rapid tumor neovascularitis, infiltration of inflammatory cells, inhibition of tumor growth and tumor apoptosis[1][2].

• UNSPSC :

  12352203

• Target :

  Apoptosis

• Related Pathways :

  Apoptosis

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer; Cardiovascular Disease

• References & Citations :

  [1]Nanney, L. B., et al., (2001) . CM101 stimulates cutaneous wound healing through an anti-angiogenic mechanism. Angiogenesis, 4 (1), 61–70. |[2]Yan, H. P., et al., (1998) . Functional studies on the anti-pathoangiogenic properties of CM101. Angiogenesis, 2 (3), 219–233.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  No Development Reported

• CAS Number :

  [2244739-55-5]